Olivier Dalmas to CRISPR-Cas Systems
This is a "connection" page, showing publications Olivier Dalmas has written about CRISPR-Cas Systems.
Connection Strength
0.100
-
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy. Nature. 2023 03; 615(7953):697-704.
Score: 0.051
-
Non-viral precision T?cell receptor replacement for personalized cell therapy. Nature. 2023 03; 615(7953):687-696.
Score: 0.050